Patents by Inventor Dan Belmont

Dan Belmont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL] PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE
    Publication number: 20230399300
    Abstract: The invention provides methods of chemical synthesis of the pharmacological agent 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate, also called CV-8972. The methods entail formation of a free base form of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethanol, also called CV-8814, as intermediate without producing a salt form of CV-8814.
    Type: Application
    Filed: August 29, 2023
    Publication date: December 14, 2023
    Inventors: Neil Buckley, Dan Belmont, Bryan Hauser, Myoung Goo Kim, Kumar Kannan
  • CRYSTAL FORMS OF 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE
    Publication number: 20230331677
    Abstract: The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Inventors: Neil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
  • Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
    Patent number: 11780811
    Abstract: The invention provides methods of chemical synthesis of the pharmacological agent 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate, also called CV-8972. The methods entail formation of a free base form of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethanol, also called CV-8814, as intermediate without producing a salt form of CV-8814.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: October 10, 2023
    Assignee: IMBRIA PHARMACEUTICALS, INC.
    Inventors: Neil Buckley, Dan Belmont, Bryan Hauser, Myoung Goo Kim, Kumar Kannan
  • Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
    Patent number: 11746090
    Abstract: The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: September 5, 2023
    Assignee: IMBRIA PHARMACEUTICALS, INC.
    Inventors: Neil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
  • CRYSTAL FORMS OF 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE
    Publication number: 20230093615
    Abstract: The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
    Type: Application
    Filed: November 14, 2022
    Publication date: March 23, 2023
    Applicant: IMBRIA PHARMACEUTICALS, INC.
    Inventors: Neil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
  • Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
    Patent number: 11530184
    Abstract: The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: December 20, 2022
    Assignee: IMBRIA PHARMACEUTICALS, INC.
    Inventors: Neil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
  • CRYSTAL FORMS OF 2-[4-[(2,3,4-TRIMETHOXPHENYL)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE
    Publication number: 20210403428
    Abstract: The invention provides polymorphs of a compound of Formula (X): The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
    Type: Application
    Filed: June 28, 2021
    Publication date: December 30, 2021
    Inventors: Neil Buckley, Dan Belmont, Sarah Bethune, Krista Diaz
  • METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL]PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE
    Publication number: 20210403429
    Abstract: The invention provides methods of chemical synthesis of the pharmacological agent 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate, also called CV-8972. The methods entail formation of a free base form of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethanol, also called CV-8814, as intermediate without producing a salt form of CV-8814.
    Type: Application
    Filed: June 28, 2021
    Publication date: December 30, 2021
    Inventors: Neil Buckley, Dan Belmont, Bryan Hauser, Myoung Goo Kim, Kumar Kannan